English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/61091
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Liver function tests and absolute lymphocyte count at day +100 are predictive factors for extensive and severe chronic graft-versus-host disease after allogeneic peripheral blood stem cell transplant

AuthorsSilva, Fernando; Pérez-Simón, José A.; Caballero-Velázquez, Teresa; Encinas, Cristina; Sánchez-Guijo, Fermín M.; Díez-Campelo, María; Colado, Enrique; Martín, Jesús; Villanueva-Gómez, Fernanda; Vázquez, Lourdes; Cañizo, María Consuelo del; Caballero, Maria Dolores; San Miguel, Jesús F.
Issue Date2010
CitationAmerican Journal of Hematology 85(4): 290-293 (2010)
AbstractChronic graft-versus-host disease (cGVHD) is the major late complication after allogeneic hematopoietic stem cell transplant [1,2]. In this article, we have analyzed the value of noninvasive day 1100 tests as predictors of severe cGVHD development in 165 patients undergoing allogeneic peripheral blood stem cell transplant (allo-PBSCT) from a matched related donor. The cumulative incidence of overall, extensive, and severe cGVHD was 67, 56, and 23%, respectively, among patients surviving >100 days after transplant. In univariate analysis, patients displaying an abnormal liver function tests (LFTs) (total bilirubin, alkaline phosphatase, and GGT > 2 times above the upper normal limit) and a low absolute lymphocyte count (ALC) (<percentile 25: 0.750 x 109/L) had a significantly higher risk of overall, extensive, and severe cGVHD. In multivariate analysis, the combination of abnormal LFT and low ALC allowed to predict the risk of overall [HR = 3.35 (95% Cl: 1.65-6.83), P < 0.001], extensive [HR = 4.22 (95% Cl: 1.96-9.12), P < 0.001], and severe cGVHD [HR = 8.17 (95% CI: 2.55-26.17), P = 0.002]. Our findings show that an increased total bilirubin, alkaline phosphatase, and GGT levels together with the ALC at day +100 are noninvasive, simple, fast, and efficient predictors of severe cGVHD development after allogeneic PBSCT.
Identifiersdoi: 10.1002/ajh.21613
issn: 0361-8609
e-issn: 1096-8652
Appears in Collections:(IBMCC) Artículos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
Show full item record
Review this work

Related articles:

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.